REG - Susquehanna Ire. Ltd Takeda Pharma.Co.Ltd Shire plc - Form 8.3 - Shire plc

Takeda Pharmaceutical CoAnnouncement

28/12/2018 09:40

RNS Number : 7009L
Susquehanna Ireland Ltd
28 December 2018
 


FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Full name of discloser:


Susquehanna International Holdings LLC ("SIHL")




(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.


N/A




(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Shire plc




(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:


N/A




(e) Date position held/dealing undertaken:
     For an opening position disclosure, state the latest practicable date prior to the disclosure


27/12/2018




(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
     If it is a cash offer or possible cash offer, state "N/A"


Takeda Pharmaceutical Company Limited



 
2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 



Class of relevant security:
 


Ordinary Shares ISIN: JE00B2QKY057
ADRs ISIN: US82481R1068
(Each ADR converts to 3 Ordinary Shares)




 
 


Interests


Short positions








Number


%


Number


%




(1) Relevant securities owned and/or controlled:


8,615,739


0.939%


91,863


0.01%




(2) Cash-settled derivatives:
 




















(3) Stock-settled derivatives (including options) and agreements to purchase/sell:


1,709,600


0.19%


481,400


0.05%




 
     TOTAL:


10,325,339


1.13%


573,263


0.06%



 
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 



Class of relevant security in relation to which subscription right exists:








Details, including nature of the rights concerned and relevant percentages:







 
 
3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales
 



Class of relevant security


Purchase/sale
 


Number of securities


Price per unit





















 
(b)        Cash-settled derivative transactions
 



Class of relevant security


Product description
e.g. CFD


Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


Number of reference securities


Price per unit








 
 















 
(c)        Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 



Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit





































 
(ii)        Exercise
 



Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit




















 
 



 
(d)        Other dealings (including subscribing for new securities)
 



Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable)








 
 











 
 
4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
 
 



 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
 
 



 
(c)        Attachments
 



Is a Supplemental Form 8 (Open Positions) attached?


YES



 
 



Date of disclosure:


28/12/2018








Contact name:


Diana Taraseviciute /Olive Fogarty








Telephone number*:


00 353 802 8419/8059







 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
 
 
 
 
 
 
 
 
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
 
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
 
 
1.         KEY INFORMATION
 



Full name of person making disclosure:


Susquehanna International Holdings LLC ("SIH LLC")




Name of offeror/offeree in relation to whose relevant securities the disclosure relates:


Shire Plc



 
2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
 



Class of relevant security


Product description e.g. call option


Written or purchased


Number of securities to which option or derivative relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date




Option on ord


PUT


Written


448


4000


American


18-Jan-19




Option on ord


PUT


Written


228


4200


American


18-Jan-19




Option on ord


PUT


Written


150


3800


American


15-Mar-19




Option on ord


PUT


Written


141


3800


American


15-Mar-19




Option on ord


PUT


Written


106


3800


American


18-Jan-19




Option on ord


PUT


Written


100


3200


American


20-Dec-19




Option on ord


PUT


Written


25


4400


American


18-Jan-19




Option on ord


PUT


Written


25


4400


American


15-Mar-19




Option on ord


PUT


Written


20


3000


American


21-Jun-19




Option on ord


PUT


Written


15


4400


American


18-Jan-19




Option on ord


PUT


Written


15


3200


American


19-Jun-20




Option on ord


PUT


Written


10


2800


American


18-Jan-19




Option on ord


PUT


Written


10


4600


American


18-Jan-19




Option on ord


PUT


Written


10


3000


American


15-Feb-19




Option on ord


PUT


Written


9


3200


American


15-Feb-19




Option on ord


PUT


Written


5


4000


American


15-Feb-19




Option on ord


PUT


Written


5


3200


American


15-Mar-19




Option on ord


PUT


Written


5


4000


American


20-Sep-19




Option on ADR


PUT


Written


3


150


American


18-Apr-19




Option on ord


PUT


Written


2


4200


American


15-Feb-19




Option on ADR


PUT


Written


1


160


American


18-Jan-19




Option on ADR


CALL


Purchased


1


150


American


18-Apr-19




Option on ord


CALL


Purchased


5


5200


American


20-Sep-19




Option on ord


CALL


Purchased


7


4000


American


18-Jan-19




Option on ADR


CALL


Purchased


8


155


American


18-Apr-19




Option on ord


CALL


Purchased


9


4000


American


15-Mar-19




Option on ord


CALL


Purchased


9


5200


American


18-Apr-19




Option on ord


CALL


Purchased


14


5200


American


15-Feb-19




Option on ADR


CALL


Purchased


19


200


American


18-Jan-19




Option on ord


CALL


Purchased


45


4800


American


18-Jan-19




Option on ord


CALL


Purchased


100


4000


American


20-Dec-19




Option on ord


CALL


Purchased


132


4800


American


15-Mar-19




Option on ord


CALL


Written


70


4400


American


15-Mar-19




Option on ord


PUT


Written


50


4200


American


18-Jan-19




Option on ord


CALL


Written


47


4600


American


18-Jan-19




Option on ord


CALL


Written


18


4600


American


15-Mar-19




Option on ord


CALL


Written


10


5600


American


20-Dec-19




Option on ord


CALL


Written


5


4400


American


18-Jan-19




Option on ord


CALL


Written


5


5600


American


19-Jun-20




Option on ord


CALL


Written


5


4800


American


20-Dec-19




Option on ord


PUT


Purchased


1


4400


American


15-Feb-19




Option on ord


PUT


Purchased


1


4400


American


18-Apr-19




Option on ADR


PUT


Purchased


1


160


American


18-Jan-19




Option on ADR


PUT


Purchased


1


160


American


18-Apr-19




Option on ord


PUT


Purchased


2


3600


American


15-Mar-19




Option on ADR


PUT


Purchased


3


150


American


18-Apr-19




Option on ADR


PUT


Purchased


3


155


American


18-Apr-19




Option on ord


PUT


Purchased


4


3600


American


18-Jan-19




Option on ord


PUT


Purchased


5


2000


American


18-Jan-19




Option on ord


PUT


Purchased


5


2400


American


18-Jan-19




Option on ord


PUT


Purchased


5


3200


American


18-Jan-19




Option on ord


PUT


Purchased


5


3800


American


21-Jun-19




Option on ord


PUT


Purchased


7


3400


American


15-Feb-19




Option on ord


PUT


Purchased


10


4800


American


15-Mar-19




Option on ord


PUT


Purchased


13


4200


American


15-Mar-19




Option on ord


PUT


Purchased


16


4000


American


15-Mar-19




Option on ord


PUT


Purchased


45


4000


American


20-Dec-19




Option on ord


CALL


Written


200


5200


American


18-Jan-19



 
3.         AGREEMENTS TO PURCHASE OR SELL ETC.
 



Full details should be given so that the nature of the interest or position can be fully understood:




 
 
 
 
 



 
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
 
The currency of all prices and other monetary amounts should be stated.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETTPBLTMBJTMJP